AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Dolutegravir Sodium, Lamivudine, Tenofovir Disoproxil Fumarate in Rwanda
1 product registered with RDA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOLUTEGRAVIR SODIUM/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE-50/ 300/300 Tablets | 1075-Rwanda FDA-2019-R1 | AUROBINDO PHARMA LIMITED | active | 16 Aug 2029 |
Dolutegravir Sodium, Lamivudine, Tenofovir Disoproxil Fumarate — RDA Registration Details
RDA (Rwanda) has 1 registered product containing Dolutegravir Sodium, Lamivudine, Tenofovir Disoproxil Fumarate, of which 1 is currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Dolutegravir Sodium, Lamivudine, Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.